What is the Peripheral Biomaterial Grafts market size?

The Peripheral Biomaterial Grafts market size is approximately USD 1.2 billion as of 2023.

What is the future outlook for the Peripheral Biomaterial Grafts market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Peripheral Biomaterial Grafts market?

Key drivers include rising cardiovascular disease prevalence and advancements in biomaterial technology.

What challenges does the Peripheral Biomaterial Grafts market face?

Challenges include high development costs and stringent regulatory requirements.

Which regions are leading the Peripheral Biomaterial Grafts market?

North America and Europe are currently leading the market due to strong healthcare infrastructure.

Who are the top companies in the Peripheral Biomaterial Grafts market?

Top companies include Medtronic, Boston Scientific, and Gore Medical, offering innovative graft solutions.

What future opportunities exist in the Peripheral Biomaterial Grafts market?

Opportunities include emerging markets and development of novel biomaterials with improved efficacy.

How is technology impacting the Peripheral Biomaterial Grafts market?

Advances in material science and 3D printing are enabling creation of customized grafts with improved performance.

What is the current regulatory landscape for Peripheral Biomaterial Grafts?

The regulatory landscape is governed by FDA and CE mark approvals, ensuring safety and efficacy of grafts.

Peripheral Biomaterial Grafts Growth Analysis & Future Outlook 2033

Peripheral Biomaterial Grafts by Application (Hospitals, Clinics, Others), by Types (Leg Grafts, Renal Artery Grafts, Arm Grafts), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 146

Forecast Period: 2026 - 2033

Market Size: $2467 million

CAGR: 6.5%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 146

Forecast Period: 2026 - 2033

Market Size: $2467 million

CAGR: 6.5%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Peripheral Biomaterial Grafts Market Size | CAGR 6.5% Forecast 2033

Peripheral Biomaterial Grafts Growth Analysis & Future Outlook 2033

🏭 Healthcare🌍 Global

Pages: 146

Forecast Period: 2026 - 2033

Market Size: $2467 million

CAGR: 6.5%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 146

Forecast Period: 2026 - 2033

Market Size: $2467 million

CAGR: 6.5%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Peripheral Biomaterial Grafts Market Overview

The Peripheral Biomaterial Grafts market refers to the industry that develops and manufactures biomaterial grafts used in peripheral procedures to repair or replace damaged tissues. As the Peripheral Biomaterial Grafts market size is expected to reach $1.4 billion by 2026, the growth outlook and market forecast indicate a promising industry expansion, driven by the increasing demand for minimally invasive procedures and the rising prevalence of peripheral artery disease. The scope of this market includes various types of biomaterial grafts, such as synthetic, biologic, and biosynthetic grafts, used in different applications, including vascular, orthopedic, and dental procedures.

Loading chart…

The current Peripheral Biomaterial Grafts market size is driven by the growing demand for minimally invasive procedures, advancements in biomaterial technology, and the increasing prevalence of peripheral artery disease. The market is expected to grow at a CAGR of 7.5% during the forecast period, driven by macro drivers such as the rising geriatric population, increasing healthcare expenditure, and the growing need for effective treatment options. Key forces shaping the industry include technology shifts, such as the development of new biomaterials and regulations, such as the stringent regulatory requirements for biomaterial grafts. The largest region in the Peripheral Biomaterial Grafts market is North America, while the fastest-growing region is Asia-Pacific, driven by the increasing demand for minimally invasive procedures and the growing healthcare infrastructure in the region.

Report Overview

Report Attribute	Details
Market size value in 2025	2.47 billion
Revenue forecast in 2033	4.30 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Cook Medical; Gore; Endologix; CR Bard (BD); Terumo; Jotec; Merit Medical; LifeTech Scientific; MicroPort; Lombard Medical; Boston Scientific; Abbott
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Peripheral Biomaterial Grafts market is poised for significant growth, driven by various factors. The market dynamics are influenced by a combination of growth drivers, restraints, opportunities, and challenges that shape the industry's trajectory.

Growth Drivers2 items

Increasing demand for minimally invasive procedures and rising Peripheral Biomaterial Grafts market size due to the growing prevalence of peripheral artery disease are driving the adoption of peripheral biomaterial grafts

Advances in biomaterial technology, such as the development of bioresorbable materials, are expanding the range of treatment options and contributing to the growth forecast of the peripheral biomaterial grafts market

Restraints2 items

High costs associated with the development and implementation of peripheral biomaterial grafts, as well as reimbursement issues, are hindering the growth of the Peripheral Biomaterial Grafts market

Stringent regulatory requirements and the need for extensive clinical trials are slowing down the approval and commercialization of new peripheral biomaterial graft products

Opportunities2 items

The growing trend of personalized medicine and the increasing focus on regenerative medicine are creating new opportunities for the development of customized peripheral biomaterial grafts

Emerging markets, particularly in Asia-Pacific, offer significant growth potential for the Peripheral Biomaterial Grafts market due to their large and aging populations, as well as improving healthcare infrastructure

Challenges2 items

The Peripheral Biomaterial Grafts market faces challenges related to the standardization of biomaterials and the need for more robust clinical evidence to support the efficacy and safety of peripheral biomaterial grafts

Intense competition among market players and the need for significant investments in research and development to stay ahead in the market are additional challenges faced by companies operating in the Peripheral Biomaterial Grafts market

Market Segmentation

Loading chart…

The Peripheral Biomaterial Grafts segmentation by application is a crucial aspect of understanding the market dynamics. The application segment is divided into various sub-types, including vascular grafts, and orthopedic grafts. Each of these sub-types contributes significantly to the overall Peripheral Biomaterial Grafts market size. For instance, vascular grafts are used to replace or bypass damaged or diseased blood vessels, while orthopedic grafts are used to repair or replace damaged bones and joints. Understanding the application segment is essential for market players to develop targeted strategies and products that cater to the specific needs of each application area.

The types segment in the Peripheral Biomaterial Grafts market includes biological and synthetic grafts. Biological grafts are derived from human or animal tissues, while synthetic grafts are made from artificial materials such as polymers. Each type of graft has its own set of advantages and disadvantages, and the choice of graft type depends on the specific application and patient needs. The types segment is a critical aspect of the Peripheral Biomaterial Grafts market, as it directly affects the market size and growth. By understanding the types segment, market players can develop products that cater to the specific needs of each type of graft, ultimately driving the growth of the Peripheral Biomaterial Grafts market.

Peripheral Biomaterial Grafts Segmentation Breakdown8 items

Application

Hospitals

Clinics

Others

Types

Leg Grafts

Renal Artery Grafts

Arm Grafts

Regional Insights

Loading chart…

The Peripheral Biomaterial Grafts market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of advanced medical technologies, favorable policies, and significant investments in healthcare infrastructure. Key drivers in North America include a mature ecosystem, high demographics of patients requiring vascular surgeries, and established infrastructure.

In Europe, key drivers include a strong regulatory framework, increasing adoption of biomaterial grafts, and a large patient population. Asia Pacific's growth is further fueled by a rapidly expanding middle-class population, increasing healthcare expenditure, and rising awareness about advanced medical treatments. Latin America and Middle East & Africa are expected to witness moderate growth, driven by improving infrastructure, growing demand for quality healthcare, and increasing foreign investments.

Competitive Landscape

The Peripheral Biomaterial Grafts market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Peripheral Biomaterial Grafts competitive landscape is driven by the ability of companies to balance these levers and differentiate their offerings. Global players tend to have an advantage in terms of economies of scale and extensive distribution networks, while local companies often focus on regional specialization and responsiveness to local market needs.

Companies in this market employ various strategies to stay competitive, including mergers and acquisitions, partnerships, product launches, expansion, research and development, and localization. Differentiation can be achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To mitigate these risks, companies must carefully consider their strategic focus and investments.

Medtronic: regional expansion

Cook Medical: premium pricing

Gore: innovation pipeline

Endologix: OEM tie-ups

CR Bard: local manufacturing

Terumo: vertical integration

Key Peripheral Biomaterial Grafts Companies13 items

Medtronic

Cook Medical

Gore

Endologix

CR Bard (BD)

Terumo

Jotec

Merit Medical

LifeTech Scientific

MicroPort

Lombard Medical

Boston Scientific

Abbott

Market Ecosystem

The Peripheral Biomaterial Grafts ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of biomaterial grafts, with each segment influencing the overall efficiency and effectiveness of the ecosystem. The Peripheral Biomaterial Grafts ecosystem is characterized by a complex interplay of participants, each playing a distinct role in the value chain analysis.

Raw material/component suppliers — providing biomaterials

OEMs / manufacturers — designing and producing grafts

Technology providers — developing underlying technologies

System integrators / EPCs — integrating grafts into larger systems

Distributors / channel partners — delivering products to end users

Service providers / after-sales — offering support and maintenance

Regulators/standards bodies — establishing industry standards

The flow of value within the Peripheral Biomaterial Grafts ecosystem is influenced by various control points, including regulatory approvals and industry standards. Dependency risks, such as input constraints and approval timelines, can impact the efficiency of the ecosystem. Moreover, switching costs, partnerships, and interoperability requirements can affect the relationships between participants. The ecosystem's dynamics can also vary by region, with different areas having distinct regulatory frameworks, market conditions, and customer needs.

Recent Industry Insights

The Peripheral Biomaterial Grafts industry has witnessed significant developments over the last 12-18 months, shaping the future of Peripheral Biomaterial Grafts industry trends. Notable partnerships have been formed, such as collaborations between leading medical device companies and research institutions, to advance the development of innovative biomaterial grafts. Recent mergers and acquisitions have also led to the expansion of product portfolios and the strengthening of market positions.

Furthermore, several product and technology launches have taken place, introducing new and improved biomaterial grafts with enhanced biocompatibility and biodegradability. Regulatory changes have also influenced the industry, with updated guidelines and standards aiming to ensure the safety and efficacy of peripheral biomaterial grafts. These developments have contributed to a shift in consumer and enterprise trends, with an increasing focus on minimally invasive procedures and personalized medicine, driving growth in the Peripheral Biomaterial Grafts market.

Analyst Overview

As the Lead Analyst, I conclude that the Peripheral Biomaterial Grafts market outlook is promising, driven by increasing demand for minimally invasive procedures and advancements in biomaterial technology. The market attractiveness is high due to the growing prevalence of peripheral artery disease and the need for effective treatment options. Competitive intensity is moderate, with key players focusing on innovation and expansion of their product portfolios.

The long-term outlook for the Peripheral Biomaterial Grafts market is favorable, with opportunities for growth in emerging markets and the development of new biomaterials. However, the market is not without risks, including regulatory challenges and supply chain disruptions. The demand-supply balance is expected to remain stable, with innovation in biomaterials and graft design driving growth. Overall, the Peripheral Biomaterial Grafts market is poised for significant growth, driven by advancements in technology and increasing demand for effective treatment options.

11 items

1. Executive Summary

2. Peripheral Biomaterial Grafts Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Peripheral Biomaterial Grafts Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Peripheral Biomaterial Grafts Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Clinics

6.1.3. Others

6.2. Global Peripheral Biomaterial Grafts Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Leg Grafts

6.2.2. Renal Artery Grafts

6.2.3. Arm Grafts

6.3. Global Peripheral Biomaterial Grafts Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Peripheral Biomaterial Grafts Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Peripheral Biomaterial Grafts Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Peripheral Biomaterial Grafts Market Competition by Key Manufacturers

8.1. Global Peripheral Biomaterial Grafts Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Peripheral Biomaterial Grafts: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Medtronic

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Cook Medical

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Gore

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Endologix

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. CR Bard (BD)

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Terumo

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Jotec

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Merit Medical

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. LifeTech Scientific

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. MicroPort

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Lombard Medical

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Boston Scientific

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Abbott

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Peripheral Biomaterial Grafts Market

Figure 4: Global Peripheral Biomaterial Grafts Market: Drivers

Figure 5: Global Peripheral Biomaterial Grafts Market: Challenges

Figure 6: Global Peripheral Biomaterial Grafts Market: Trends

Figure 7: Global Peripheral Biomaterial Grafts Market: Opportunity

Figure 8: Global Peripheral Biomaterial Grafts Market: Restraint

Figure 9: Global Peripheral Biomaterial Grafts Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Peripheral Biomaterial Grafts Market Value (USD Million) By Region

Figure 15: Global Peripheral Biomaterial Grafts Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Peripheral Biomaterial Grafts Market Value (USD Million) By Region

Figure 23: Global Peripheral Biomaterial Grafts Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

79 items

Table 1: Market Segmentation Analysis

Table 2: Global Peripheral Biomaterial Grafts Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Peripheral Biomaterial Grafts Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Peripheral Biomaterial Grafts Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Peripheral Biomaterial Grafts Market Value (USD Million) By Region

Table 10: Global Peripheral Biomaterial Grafts Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Peripheral Biomaterial Grafts Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Peripheral Biomaterial Grafts Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Peripheral Biomaterial Grafts Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Medtronic Basic Information And Sales Area

Table 31: Medtronic. Products Portfolio

Table 32: Cook Medical Basic Information And Sales Area

Table 33: Cook Medical. Products Portfolio

Table 34: Gore Basic Information And Sales Area

Table 35: Gore. Products Portfolio

Table 36: Endologix Basic Information And Sales Area

Table 37: Endologix. Products Portfolio

Table 38: CR Bard (BD) Basic Information And Sales Area

Table 39: CR Bard (BD). Products Portfolio

Table 40: Terumo Basic Information And Sales Area

Table 41: Terumo. Products Portfolio

Table 42: Jotec Basic Information And Sales Area

Table 43: Jotec. Products Portfolio

Table 44: Merit Medical Basic Information And Sales Area

Table 45: Merit Medical. Products Portfolio

Table 46: LifeTech Scientific Basic Information And Sales Area

Table 47: LifeTech Scientific. Products Portfolio

Table 48: MicroPort Basic Information And Sales Area

Table 49: MicroPort. Products Portfolio

Table 50: Lombard Medical Basic Information And Sales Area

Table 51: Lombard Medical. Products Portfolio

Table 52: Boston Scientific Basic Information And Sales Area

Table 53: Boston Scientific. Products Portfolio

Table 54: Abbott Basic Information And Sales Area

Table 55: Abbott. Products Portfolio

Table 56: Global Market Value (USD Million) (2025-2032) By Application

Table 57: Global Market Share (%) By Application (2032)

Table 58: Global Market Value (USD Million) (2025-2032) By Types

Table 59: Global Market Share (%) By Types (2032)

Table 60: Global Peripheral Biomaterial Grafts Market Value (USD Million) By Region

Table 61: Global Peripheral Biomaterial Grafts Market Share (%) By Region (2025-2032)

Table 62: North America Market Value (USD Million) (2025-2032) By Country

Table 63: North America Market Value (USD Million) (2025-2032) By Application

Table 64: North America Market Value (USD Million) (2025-2032) By Types

Table 65: Europe Market Value (USD Million) (2025-2032) By Country

Table 66: Europe Market Value (USD Million) (2025-2032) By Application

Table 67: Europe Market Value (USD Million) (2025-2032) By Types

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 69: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 71: South America Market Value (USD Million) (2025-2032) By Country

Table 72: South America Market Value (USD Million) (2025-2032) By Application

Table 73: South America Market Value (USD Million) (2025-2032) By Types

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 75: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 77: Research Programs/Design For This Report

Table 78: Key Data Information From Secondary Sources

Table 79: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Peripheral Biomaterial Grafts Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.47 billion
Revenue forecast in 2033	4.30 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Cook Medical; Gore; Endologix; CR Bard (BD); Terumo; Jotec; Merit Medical; LifeTech Scientific; MicroPort; Lombard Medical; Boston Scientific; Abbott
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options